| No. | Comp. |
| In vitro Cytotoxicity IC50 (µM) • | |
| HePG-2 | MCF-7 | |||
| •• | DOXORUBICIN | 4.50 ± 0.3 | 4.17 ± 0.2 | |
| 1 | 1 |
| 65.62 ± 3.4 | 53.40 ± 3.3 |
| 2 | 3a |
| 100< | 100< |
| 3 | 3b |
| 100< | 100< |
| 4 | 3c |
| 100< | 84.71 ± 4.4 |
| 5 | 5a |
| 100< | 100< |
| 6 | 5b |
| 93.01 ± 4.9 | 78.29 ± 4.0 |
| 7 | 5c |
| 81.35 ± 4.2 | 69.48 ± 3.7 |
| 8 | 6 |
| 39.42 ± 2.6 | 42.23 ± 2.9 |
| 9 | 7c |
| 86.35 ± 4.4 | 67.51 ± 3.5 |
| 10 | 8 |
| 48.28 ± 2.8 | 45.67 ± 3.0 |
| 11 | 3c |
| 39.52 ± 3.6 | 44.65 ± 1.8 |
| 12 | 9 |
| 32.16 ± 2.4 | 37.20 ± 2.6 |
| 13 | 10 |
| 52.04 ± 2.9 | 38.17 ± 2.5 |
| 14 | 11 |
| 19.87 ± 1.6 | 14.35 ± 1.2 |
| 15 | 13a |
| 73.55 ± 3.6 | 57.18 ± 3.4 |
| 16 | 13b |
| 64.19 ± 3.3 | 49.65 ± 3.1 |
| 17 | 13c |
| 58.29 ± 3.1 | 31.48 ± 2.3 |
| 18 | 14a |
| 100< | 100< |
| 19 | 14b |
| 100< | 100< |
| 20 | 14c |
| 100< | 74.19 ± 3.9 |
| 21 | 15 |
| 29.71 ± 2.3 | 17.26 ± 1.4 |
| 22 | 16 |
| 26.10 ± 2.1 | 28.06 ± 2.2 |
| 23 | 17 |
| 8.71 ± 0.7 | 7.18 ± 0.5 |